Parexel expands eclinical technology business
This article was originally published in Scrip
Parexel International has completed the acquisition of ClinPhone to become a major supplier of eClinical technology. ClinPhone will become part of Parexel's wholly owned Perceptive Informatics. The combined company will provide services such as ClinPhone's interactive voice and web response systems, DataLabs, an electronic data capture and clinical data management system, and clinical trial management systems. In June, Parexel offered 135p per share, valuing the entire issued ordinary share capital of ClinPhone at around $182 million. The offer price represented an 86% premium to the ClinPhone share price on the London Stock Exchange, Parexel said at the time. It plans to issue financial information for the first quarter of fiscal 2009 on September 8th.
You may also be interested in...
Laura Gonz�lez-Molero will be celebrating her first anniversary as President of Bayer HealthCare Pharmaceuticals, Latin America this month. With Bayer posting total sales of €1.05bnin Latin America in 2014, up 13% over 2013, Ms Gonz�lez-Molero should be pleased with a successful inaugural year. Resolute in her belief that innovation, "part of Bayer's DNA," will determine the company's long-term success in Latin America, rather than growth through acquisition, Ms Gonz�lez-Molero talks to Scrip about her personal ambitions for the company and the region.
A decade since its formation Anvisa, Brazil's medicines regulator, has shaken up the country's framework for ensuring drug quality. Yet the agency's approaches to drug pricing and registration have left some multinationals wanting, reports Sita Shah.
Elan is raising $1.5 billion in bonds to refinance its existing debt and for general corporate purposes, it says.